303 related articles for article (PubMed ID: 30115676)
21. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
Yiu EM; Laughlin S; Verhey LH; Banwell BL;
J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
[TBL] [Abstract][Full Text] [Related]
22. Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study.
Chew SH; Achmad Sankala HB; Chew E; Md Arif MHB; Mohd Zain NR; Hashim H; Koya Kutty SB; Chee YC; Mohd Saleh NB; Ong BH; Viswanathan S
Mult Scler Relat Disord; 2023 Nov; 79():104992. PubMed ID: 37717306
[TBL] [Abstract][Full Text] [Related]
23. Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.
Law M; Hamburger M; Johnson G; Inglese M; Londono A; Golfinos J; Zagzag D; Knopp EA
Technol Cancer Res Treat; 2004 Dec; 3(6):557-65. PubMed ID: 15560713
[TBL] [Abstract][Full Text] [Related]
24. Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging.
Enzinger C; Strasser-Fuchs S; Ropele S; Kapeller P; Kleinert R; Fazekas F
Mult Scler; 2005 Apr; 11(2):135-9. PubMed ID: 15794384
[TBL] [Abstract][Full Text] [Related]
25.
Huhn K; Mennecke A; Linz P; Tschunko F; Kästle N; Nagel AM; Uder M; Dörfler A; Linker RA; Engelhorn T
J Neurol Sci; 2017 Aug; 379():163-166. PubMed ID: 28716233
[TBL] [Abstract][Full Text] [Related]
26. Tumefactive Demyelinating Lesions and Pregnancy.
Plantone D; Piantadosi C; Ruggieri S; Anelli V; Koudriavtseva T
Neurol India; 2019; 67(6):1519-1521. PubMed ID: 31857550
[TBL] [Abstract][Full Text] [Related]
27. Tumefactive demyelinating lesions (TDLs): A case series of clinicoradiological features.
Jain RS; Khan I; Kandelwal K; Desai T
Clin Neurol Neurosurg; 2017 Nov; 162():91-94. PubMed ID: 28987645
[TBL] [Abstract][Full Text] [Related]
28. Atypical idiopathic inflammatory demyelinating lesions (IIDL): conventional and diffusion-weighted MR imaging (DWI) findings in 42 cases.
Koelblinger C; Fruehwald-Pallamar J; Kubin K; Wallner-Blazek M; van den Hauwe L; Macedo L; Puchner SB; Thurnher MM
Eur J Radiol; 2013 Nov; 82(11):1996-2004. PubMed ID: 23993757
[TBL] [Abstract][Full Text] [Related]
29. [Tumefactive demyelinating lesion (TDL)].
Nakajima A; Kawachi I
No Shinkei Geka; 2021 Mar; 49(2):376-382. PubMed ID: 33762460
[TBL] [Abstract][Full Text] [Related]
30. Intraaxial brain masses: MR imaging-based diagnostic strategy--initial experience.
Al-Okaili RN; Krejza J; Woo JH; Wolf RL; O'Rourke DM; Judy KD; Poptani H; Melhem ER
Radiology; 2007 May; 243(2):539-50. PubMed ID: 17456876
[TBL] [Abstract][Full Text] [Related]
31. Perfusion Imaging of Tumefactive Demyelinating Lesions Compared to High Grade Gliomas.
Parks NE; Bhan V; Shankar JJ
Can J Neurol Sci; 2016 Mar; 43(2):316-8. PubMed ID: 26573406
[No Abstract] [Full Text] [Related]
32. Tumefactive Demyelinating Lesions in Children: A Rare Case of Conus Medullaris Involvement and Systematic Review of the Literature.
Pérez CA; Patnaik A; Oommen S; Redko A; Mathis SB
J Child Neurol; 2020 Sep; 35(10):690-699. PubMed ID: 32552343
[TBL] [Abstract][Full Text] [Related]
33. Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions.
Ayrignac X; Rigau V; Lhermitte B; Vincent T; de Champfleur NM; Carra-Dalliere C; Charif M; Collongues N; de Seze J; Hebbadj S; Ahle G; Oesterlé H; Cotton F; Durand-Dubief F; Marignier R; Vukusic S; Taithe F; Cohen M; Guennoc AM; Kerbrat A; Edan G; Carsin-Nicol B; Allou T; Sablot D; Thouvenot E; Ruet A; Magy L; Boncoeur-Martel MP; Labauge P; Kremer S
J Neurol; 2019 Jul; 266(7):1743-1755. PubMed ID: 31016376
[TBL] [Abstract][Full Text] [Related]
34. Tumefactive demyelination: clinical, imaging and follow-up observations in thirty-nine patients.
Nagappa M; Taly AB; Sinha S; Bharath RD; Mahadevan A; Bindu PS; Saini JS; Prasad C; Shankar SK
Acta Neurol Scand; 2013 Jul; 128(1):39-47. PubMed ID: 23277913
[TBL] [Abstract][Full Text] [Related]
35. Demyelination preceding a diagnosis of central nervous system lymphoma.
Kalus S; Di Muzio B; Gaillard F
J Clin Neurosci; 2016 Feb; 24():146-8. PubMed ID: 26455545
[TBL] [Abstract][Full Text] [Related]
36. Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Totaro R; Di Carmine C; Splendiani A; Torlone S; Patriarca L; Carrocci C; Sciamanna S; Marini C; Carolei A
Neurol Sci; 2016 Jul; 37(7):1113-7. PubMed ID: 27083895
[TBL] [Abstract][Full Text] [Related]
37. Tumefactive demyelinating lesions.
Dagher AP; Smirniotopoulos J
Neuroradiology; 1996 Aug; 38(6):560-5. PubMed ID: 8880719
[TBL] [Abstract][Full Text] [Related]
38. Pediatric tumefactive demyelination: case series and review of the literature.
McAdam LC; Blaser SI; Banwell BL
Pediatr Neurol; 2002 Jan; 26(1):18-25. PubMed ID: 11814730
[TBL] [Abstract][Full Text] [Related]
39. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
[TBL] [Abstract][Full Text] [Related]
40. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
Suh CH; Kim HS; Jung SC; Park JE; Choi CG; Kim SJ
J Magn Reson Imaging; 2019 Aug; 50(2):560-572. PubMed ID: 30637843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
